PlainRecalls
FDA Drug Moderate Class II Terminated

Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reported: February 22, 2017 Initiated: February 2, 2017 #D-0479-2017

Product Description

Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
17,473 cartons
Distribution
Nationwide in the United States
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.. Recalled by Teva Pharmaceuticals USA. Units affected: 17,473 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 22, 2017. Severity: Moderate. Recall number: D-0479-2017.